1 – 8 of 8
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Factors influencing stone-free rate of Extracorporeal Shock Wave Lithotripsy (ESWL); a cohort study
Wagenius, Magnus LU ; Oddason, Karl LU ; Utter, Maria LU
; Popiolek, Marcin
; Forsvall, Andreas
LU
; Lundström, Karl Johan
and Linder, Adam
LU
(2022)
In Scandinavian Journal of Urology
56(3).
p.237-243
- Contribution to journal › Article
- 2019
-
Mark
An evaluation of zonisamide, including its long-term efficacy, for the treatment of focal epilepsy
- Contribution to journal › Article
-
Mark
Ureteroscopy : A population based study of clinical complications and possible risk factors for stone surgery
Wagenius, Magnus LU ; Rydberg, Mattias ; Popiolek, Marcin ; Forsvall, Andreas LU
; Stranne, Johan
and Linder, Adam
LU
(2019)
In Central European Journal of Urology
72(3).
p.285-295
- Contribution to journal › Article
-
Mark
Sicca/Sjögren's syndrome triggered by PD-1/PD-L1 checkpoint inhibitors. Data from the International Immunocancer Registry (ICIR)
- Contribution to journal › Article
- 2017
-
Mark
Complications in extracorporeal shockwave lithotripsy : a cohort study
- Contribution to journal › Article
- 2012
-
Mark
Duration of L-dopa and dopamine agonist monotherapy in Parkinson´s disease
Nissen, T ; Newman, E. J. ; Grosset, K. A. ; Daghem, M ; Pal, G. ; Stewart, M. ; Odin, Per LU
; Macphee, G. J.
and Gosset, D. G.
(2012)
In Scottish Medical Journal
57(4).
p.217-220
- Contribution to journal › Article
-
Mark
Incidence of fractures causing hospitalisation in prostate cancer patients: Results from the population-based PCBaSe Sweden
- Contribution to journal › Article
- 2006
-
Mark
Tolerability, efficacy and pharmacokinetics of bicalutamide 300 mg, 450 mg or 600 mg as monotherapy for patients with locally advanced or metastatic prostate cancer, compared with castration
- Contribution to journal › Article